Zatosetron maleate

N/A

Report date: 2022/05/16 18:00:28
NME

Base Information

Drug NameZatosetron maleate
Drug Alias Namezatosetronum马来酸扎托司琼扎托司琼LY-277359LY-191617
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG